(Q53595735)

16 May 2018

title

A novel Bcl-2/Bcl-X(L)/Bcl-w inhibitor ABT-737 as therapy in multiple myeloma. (English)

1 reference

16 May 2018

author name string

Chauhan D

1

1 reference

16 May 2018

Velankar M

2

1 reference

16 May 2018

Brahmandam M

3

1 reference

16 May 2018

Hideshima T

4

1 reference

16 May 2018

Podar K

5

1 reference

16 May 2018

Richardson P

6

1 reference

16 May 2018

Schlossman R

7

1 reference

16 May 2018

Ghobrial I

8

1 reference

16 May 2018

Raje N

9

1 reference

16 May 2018

Munshi N

10

1 reference

16 May 2018

Anderson KC

11

1 reference

16 May 2018

language of work or name

English

0 references

publication date

2 October 2006

1 reference

16 May 2018

published in

Oncogene

1 reference

16 May 2018

volume

26

1 reference

16 May 2018

issue

16

1 reference

16 May 2018

page(s)

2374-2380

1 reference

16 May 2018

https://scigraph.springernature.com/pub.10.1038/sj.onc.1210028

exact match

0 references

cites work

Apoptosis: checkpoint at the mitochondrial frontier.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210028

Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210028

A novel orally active proteasome inhibitor induces apoptosis in multiple myeloma cells with mechanisms distinct from Bortezomib

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210028

Proteasome inhibition in multiple myeloma: therapeutic implication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210028

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210028

Killing cancer cells by flipping the Bcl-2/Bax switch.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210028

Identification of small-molecule inhibitors of interaction between the BH3 domain and Bcl-xL

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210028

Inhibition of TRAIL-induced apoptosis by Bcl-2 overexpression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210028

VEGF induces Mcl-1 up-regulation and protects multiple myeloma cells against apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210028

The inhibitors of apoptosis: there is more to life than Bcl2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210028

Potentiation of dexamethasone-, paclitaxel-, and Ad-p53-induced apoptosis by Bcl-2 antisense oligodeoxynucleotides in drug-resistant multiple myeloma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210028

Molecular sequelae of histone deacetylase inhibition in human malignant B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210028

Chromatin condensation during apoptosis is accompanied by degradation of lamin A+B, without enhanced activation of cdc2 kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210028

An inhibitor of Bcl-2 family proteins induces regression of solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210028

The proteasome inhibitor bortezomib induces apoptosis in mantle-cell lymphoma through generation of ROS and Noxa activation independent of p53 status

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210028

Structural biology of the Bcl-2 family of proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210028

Proteasome inhibitors trigger NOXA-mediated apoptosis in melanoma and myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210028

Chemosensitization of myeloma plasma cells by an antisense-mediated downregulation of Bcl-2 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210028

Cell death: the significance of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210028

Mcl-1 is overexpressed in multiple myeloma and associated with relapse and shorter survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210028

Multiple myeloma cells are protected against dexamethasone-induced apoptosis by insulin-like growth factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210028

Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210028

A lively meeting on a deathly topic

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210028

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.ONC.1210028

1 reference

16 May 2018

PubMed ID

17016430

1 reference

16 May 2018